Earnings Call Transcripts

Access detailed transcripts and key takeaways from company earnings calls

All Earnings Calls

PSNL November 4, 2025

Personalis Q3 2025 Earnings Call - Accelerating Clinical Adoption Amid Biopharma Volatility and Coverage Milestones

Personalis delivered a solid Q3 2025 performance marked by strong clinical test volume growth and progress on medical coverage fronts despite ongoing biopharma sector instability and logistical challe...

  • Q3 clinical test volume reached 4,388, up 26% sequentially and 364% year-over-year, driven by expanding physician adoption of NeXT Personal.
  • Personalis now has over 700 physicians ordering NeXT Personal, signifying strong market penetration and retention.
  • Revenue for Q3 was $14.5 million, above guidance, but total company revenue declined 44% year-over-year primarily due to wind-down of Natera and VA MVP contracts and completion of Moderna’s melanoma trial.
  • +10 more takeaways
CRCT November 4, 2025

Cricut Q3 2025 Earnings Call - Platform Growth and AI Lead a Campaign to Reignite Engagement Amid Tariff Headwinds

Cricut's Q3 2025 report reveals modest 2% sales growth contrasting with a doubling of operating income and EPS, fueled by strong platform performance and strategic marketing shifts. The company is agg...

  • Q3 2025 revenue grew 2% year-over-year to $170.4 million, with platform revenue up 7% and product revenue down 3%.
  • Operating income surged 114% to $22.7 million, with EPS doubling to $0.10 per share, driven largely by a better revenue mix and margin expansion.
  • Paid subscribers increased 6% to over 3 million, reinforcing platform strength despite a nearly flat active user base year-over-year.
  • +9 more takeaways
OUST November 4, 2025

Ouster Q3 2025 Earnings Call - Record Sensor Shipments and Strategic Growth in Physical AI Solutions

Ouster reported its 11th consecutive quarter of revenue growth in Q3 2025, posting $39.5 million driven by a record shipment of over 7,200 LiDAR sensors. The company is advancing across multiple verti...

  • Q3 revenue reached a record $39.5 million, marking 11 consecutive quarters of growth with 41% YoY increase.
  • Shipped over 7,200 LiDAR sensors, the highest quarterly volume to date, serving multiple industries.
  • Gross margin at 42%, with a long-term target of 35%-40%, despite tariff headwinds.
  • +13 more takeaways
CORT November 4, 2025

Corcept Therapeutics Q3 2025 Earnings Call - Poised for Growth with Relacorilant Approvals and Expanding Oncology Pipeline

Corcept Therapeutics reported Q3 2025 revenue of $207.6 million, up from $182.5 million year-over-year, while net income declined to $19.7 million from $47.2 million. Despite challenges with pharmacy ...

  • Corcept's Q3 2025 revenue rose to $207.6 million from $182.5 million in prior year, while net income declined to $19.7 million.
  • Korlym prescriptions reached record levels, with a 42.5% increase in tablets shipped versus Q3 2024, driven by a broader prescriber base.
  • Existing pharmacy capacity constraints delayed full demand fulfillment; transition to a new pharmacy began in Q4 to address this, with plans to add a second and third specialty pharmacy in 2026.
  • +7 more takeaways
EGHT November 4, 2025

8x8, Inc. Q2 2026 Earnings Call - Innovation Drives Growth Amid Transition to Usage-Based Revenue

8x8 reported a strong Q2 2026 with total revenue of $184.1 million, surpassing guidance and marking the second consecutive quarter of year-over-year growth. The company highlighted significant innovat...

  • 8x8 reported Q2 total revenue of $184.1 million, beating the high end of guidance.
  • Service revenue grew 2.3% year-over-year, with 6% growth ex-Fused customers.
  • Usage-based revenue grew to 19% of service revenue, up from 13% a year ago, reflecting strong adoption of CPaaS and AI products.
  • +13 more takeaways
AVNW November 4, 2025

Aviat Networks Q1 FY2026 Earnings Call - Strong Revenue Growth and New Public Safety Router Expansion

Aviat Networks kicked off fiscal 2026 with a solid first quarter, delivering a 21.4% revenue increase year-over-year to $107.3 million and a turnaround from last year’s losses to a non-GAAP EPS of $0....

  • Aviat reported $107.3 million in Q1 FY2026 revenue, up 21.4% versus prior year, marking a solid start to the fiscal year.
  • Non-GAAP gross margin rose sharply to 33.8%, driven by favorable product and regional mix and higher volumes.
  • Adjusted EBITDA turned positive at $9.1 million, up $16.8 million year-over-year, reflecting operational improvements and disciplined cost management.
  • +9 more takeaways
CRSR November 4, 2025

Corsair Gaming Q3 2025 Earnings Call - Double-Digit Revenue Growth and Margin Expansion Despite Memory Market Tightness

Corsair Gaming delivered a robust Q3 2025 performance, with 14% revenue growth to $345.8 million and profit expansion outpacing top-line increases. Strong product launches, including the Vanguard 96 K...

  • Corsair reported 14% year-over-year revenue growth in Q3 2025, reaching $345.8 million, with profitability growing faster than revenue.
  • Gross margin improved 400 basis points to 26.9%, driven by an improved product mix and higher growth segments.
  • Components and systems segment revenue increased over 15% year-over-year, benefiting from NVIDIA 5000 series GPU launches and enthusiast upgrade cycles.
  • +7 more takeaways
AMGN November 4, 2025

Amgen Q3 2025 Earnings Call - Repatha's Landmark Data and Robust Pipeline Drive Strong Growth

Amgen reported a robust third quarter with 12% revenue growth and 14% volume increase, fueled by broad-based product momentum and a deep pipeline advancing in four key therapeutic areas. The company a...

  • Amgen achieved 12% revenue growth and 14% volume growth in Q3 2025, with 16 products growing double digits.
  • Repatha sales surged 40% to $794 million in Q3 and annualize around $3 billion, driven by new Vesalius CV data showing benefits in primary prevention of cardiovascular events.
  • Amgen launched Amgen Now, a direct-to-patient platform offering Repatha at roughly 60% below the U.S. list price to bolster patient access and affordability.
  • +17 more takeaways
PINS November 4, 2025

Pinterest Q3 2025 Earnings Call - AI-driven visual search and shopper engagement fuel 17% revenue growth

Pinterest reported a strong third quarter with 17% year-over-year revenue growth to $1.049 billion, driven by 600 million monthly active users and a dominant Gen Z base. The company is evolving into a...

  • Pinterest reached 600 million monthly active users, growing 12% year-over-year, with Gen Z as the largest and fastest-growing demographic comprising over 50% of users.
  • Q3 revenue grew 17% year-over-year to $1.049 billion, led by retail, telecom, entertainment, and emerging categories like financial services.
  • The company is transforming into an AI-powered visual shopping assistant with proprietary multimodal search models and a voice-activated Pinterest Assistant now in beta.
  • +9 more takeaways
AMWL November 4, 2025

AmWell Q3 2025 Earnings Call - Advancing AI-Driven Platform to Achieve Cash Flow Break-Even by End of 2026

AmWell delivered Q3 2025 results ahead of expectations, showing progress toward their strategic goal of cash flow break-even by year-end 2026. The company is doubling down on a two-pronged plan: lever...

  • Q3 revenue totaled $56.3 million, down 8% YoY, but up 1.3% excluding divested APC business.
  • Subscription revenue grew 18% YoY, comprising 55% of total revenue versus 43% a year ago.
  • Total visit volume declined 21% to 1.1 million visits, aligned with expectations; normalized visits down 3.5% excluding APC.
  • +14 more takeaways